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Abstract 
Phytotherapy is considered to be lowest lethal or 
has no side effects in contrast to current allopathic 
medicines. The intention of the present investigation 
was to assess the therapeutic efficacy of Nephelium 
longan extract in an animal model of diabetes. So in 
this research we have performed phytochemical 
screening of methanolic extracts of peel (MNLP)  
and seeds (MNLS) of N. longan along with their 
hypoglycemic study in 18 h fasted normal and 
alloxan induced diabetic rats. Plant extracts at a 
dose of 150 mg/kg and 300 mg/kg body weight 
were administered orally in fasting glucose loaded 
rat with regard to normal control during 2 h study 
period and in alloxan induced (110 mg/kg body 
weight i.p.) diabetic rat in comparison with reference 
drug Metformin hydrochloride (150 mg/kg) during 7 
days test period. Preliminary phytochemical 
screening showed that MNLP and MNLS exhibited 
positive response to alkaloids, tannins and 
flavonoids. Findings confirmed that the continuous 
post-treatment for 7 days with both extracts showed 
significant (P < 0.05) hypoglycemic activity in OGTT 
and normoglycemic rats and insignificant 
antidiabetic effects in alloxan induced rat models in 
dose dependent manner. Further, isolation and 
establishment of exact mechanism of action of 
precise compounds from MNLP and MNLS have to 
be continued in the recent future. 
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1. Introduction  
 
 
From the ancient time man has used different 
parts of plants in healing and prevention of 
numerous ailments. Traditionally all medicinal 
preparations were derived from plants, 
whether in the plain form of plant parts or in 
the more composite form of crude extracts, 
combinations, etc. (Ayyanar and Ignacimuthu, 
2009). Plant derived medicines are extensively 
used because they are comparatively safer 
than the synthetic alternatives, they are simply 
available and cheaper (Iwu et al., 1999). 
Medicinal plants are vital sources for novel 
chemical compounds with potent 
pharmacological activities (Farnsworth, 
1989).They act as natural reservoirs for 
antidiabetic, anti-inflammatory, analgesic, 
antidiarrheal, antipyretic agents. In the 
developed countries 25 percent of the medical 
drugs are based on plants and their 
derivatives and the use of medicinal plants is 
well known among the indigenous people in 
rural areas of many developing countries 
(Ayyanar and Ignacimuthu, 2009). Diabetes 
mellitus is a chronic metabolic disorder 
distinguished by hyperglycemia, glycosuria, 
hyperlipidaemia, negative nitrogen balance, 
and occasionally ketonemia (Tripathi, 
2010).The extensive pathological alteration 
escorts to obstacles similar to retinopathy, 
microangiopathy, and nephropathy (Akhtar 
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and Ali, 1980). Globally the prevalence of 
diabetes mellitus is increasing. Although 
research for diabetes has resulted in newer 
insulin preparations and medications, 
improved systems for insulin delivery and self-
monitoring of blood glucose, and more 
aggressive treatment of diabetes 
complications and comorbid conditions (Daly, 
2003), majority of the oral hypoglycemic 
agents, presently in use, produce severe side 
effects like hypoglycemic coma and hepato-
renal disturbances.  Hence, there is a burning 
need to explore safer and more efficient 
hypoglycemic mediators. Still today 
management of diabetes with no side effects 
is a great challenge to the medical community.  
 
There is continuous hunt for alternative drugs. 
Hence, it is prudent to search for options in 
herbal medicine for diabetes as well. 
Conventional antidiabetic plants might offer 
new oral hypoglycemic agents, which can 
counteract the high expenditure and poor 
accessibility of the present medicines for many 
rural peoples in developing countries. 
  
Nephelium longan (Family, Sapindaceae; 
Bengali name, Kathlichu) is a tree of 30 or 40 
ft in stature and 45 ft in width, with rough-
barked trunk to 2 and 1/2 ft thick and long, 
spreading, slightly drooping and heavily 
foliaged branches. Longan is a subtropical 
fruit, closely allied to the glamorous lychee 
also known as dragon's eye or eyeball is 
largely grown in China and South East Asia, 
including Thailand, Vietnam and the 
Philippines (Menzel et al., 1995). The color of 
fruit peel is brown or light-brown with white 
translucent flesh. The seed is round and black 
with a spherical white spot at the base. The 
flesh is sweet and juicy; therefore, it can be 
consumed in both fresh and processed 
products, such as canned longan in syrup or 
as dried fruit. 
  
The flesh extracts have been reported to use 
in stomachic, insomnia, neurasthenic neurosis 
and also act as febrifuge, vermifuge and 
antidot (Morton, 1987). The extract of longan 
arillus exhibited anxiolytic-like, sedative and 
analgesic effects (Okuyama et al., 1999). 
Peels and seeds extract showed CNS 
depressant and antinocieptive properties (Ripa 
et al., 2012). The plant extracts also found to 
be anti-mutagenic (Minakata, et al., 1985) 
anticarcinogenic (Sherine, et al., 2010) 
antibacterial, cytotoxic and antioxidant effects 
(Ripa et al., 2010). Ellagitannins, corilagin, 
acetonyl-geraniin were reported in seeds of 
longan (Cheng et al., 1995; Hsu et al., 1994; 
Rangkadilok et al., 2005).Longan arillus was 
shown to contain adenosine (Okuyama et al., 
1999) and gallic acid (Rangkadilok et al., 
2005). 
 
Keeping all these in view and since 
conventional medicine is an imperative source 
of potentially useful novel compounds for the 
development of chemotherapeutic agents; we 
have investigated the methanolic extracts of 
peels and seeds of the fruits of N. longan for 
their hypoglycemic effect.   
 
2. Material and Methods 
 
2.1. Collection and Identification of Plant 
In this investigation, the fresh fruits of N. 
longan were collected from, Dhaka, 
Bangladesh in August, 2012. The fresh leaves 
and fruits of longan were identified by Dr. 
Mahbubur Rahaman, Associate Professor of 
Department of Botany, Rajshahi University, 
Rajshahi and National Herbarium of 
Bangladesh, whose voucher specimen no. is 
36664 and is maintained in our laboratory for 
future reference. From the collected fruits peel 
and seeds were separated and dried for one 
week and pulverized into a coarse powder with 
a suitable grinder. The powder was stored in 
an airtight container, and was kept in a cool, 
dark and dry place for analysis. 
 
2.2. Preparation of Extracts 
Approximately 400 g of powdered materials of 
both the peel and seed were taken in two 
different clean, flat bottomed glass containers 
and were deepen in 800 ml of 95% methanol. 
The containers with their contents were sealed 
and kept for a period of 7 days associated with 
occasional shaking and stirring. The two 
mixtures then underwent a coarse filtration by 
a piece of clean, white cotton plug and were 
filtered through Whatman filter paper (Bibby 
200, Sterilin Ltd., UK). The filtrates (methanolic 
extract) obtained were evaporated using rotary 
evaporator. The methanolic portion of the peel 
delivered a reddish brown gummy precipitate 
which was designated as MNLP; whereas, the 
seed portion yield brown mass which was 
named as MNLS. The extracts were 
transferred to two different closed containers 
for further use and fortification. 
 
2.3. Chemicals and drugs  
Alloxan (Fluka, Germany), Tween-80, normal 
saline solution (Beximco Infusion Ltd., 
Bangladesh), Metformin (Square 
Pharmaceuticals Ltd., Bangladesh), were 
procured and used in the experiment. All 
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chemicals in this investigation were of 
analytical reagent grade. 
 
2.4. Phytochemical analysis 
The MNLP and MNLS were subjected to 
qualitative chemical screening for the 
identification of bioactive constituents (tannins, 
alkaloids, flavonoids etc.) using standard 
procedures (Trease andEvans, 2001). 
 
2.5. Animals 
Young Long-Evans rats of either sex weighing 
about 80-120gm were used to conduct the 
research. The rats were procured from the 
animal Research Branch of the International 
Centre for Diarrhoeal Disease and Research, 
Bangladesh (ICDDRB). They were kept in 
standard environmental condition (at 24.0±0°C 
temperature & 55-65% relative humidity and 
12 hours light/dark cycle) for two weeks for 
acclimation and fed ICDDRB formulated 
rodent food and tap water ad libitum. All 
animals were fasted over night before tests 
while providing tap water ad libitum. 
   
2.6. Ethical Approval 
The guidelines followed for animal experiment 
were accepted by the institutional animal 
ethical committee (Zimmermann, 1983).          
 
2.7. Oral toxicity studies 
An acute oral toxicity study was followed 
according to “Organization for Environmental 
Control Development” guidelines (OECD: 
Guidelines 420; Fixed Dose Method) for oral 
administration of methanol extract. Long Evan 
rats (N=6, 150-200 g) overnight fasted for 18 
were used for the study. Different doses of 
plant extracts up to 1600 mg/kg, p.o. was 
administered and animals were observed for 
the first 3 hours of administration and mortality 
recorded within 48 hours. 
 
2.8. Induction of diabetes in rats 
Diabetes was created by a single dose 
subcutaneous injection of freshly prepared 
alloxan monohydrate dissolved in normal 
saline to overnight fasted rodents. Blood 
glucose level (BGL) was measured by using 
one-touch glucometer and diabetes was 
confirmed after 72 hr of alloxanisation. Rats 
which showed hyperglycemia (BGL > 10 
mml/l) were chosen for research. 
 
2.9. Experimental Design 
 
2.9.1. Oral Glucose Tolerance Test (OGTT) 
In the beginning, hypoglycemic activity of plant 
extracts was checked in overnight fasted 
normal rats, which were uniformly alienated 
into six groups of each. Normal control group 
received only vehicle (1 normal saline p.o.) 
and standard group received 1 ml of reference 
drug Metformin in the vehicle (150 mg/kg, 
p.o.), while group from third to sixth were 
administered with 1 ml of MNLP and MNLS at 
150 and 300 mg/kg, p.o. doses respectively. 
Subsequent 30 min post extract administration 
all the rodents were fed with glucose (2 g/kg). 
Blood samples were taken from tail vein prior 
to dosing and then at 30, 60, 90 and 120 min 
after glucose administration. The fasting blood 
glucose level was analyzed using glucose-
oxidase-peroxide reactive strips (Accu-chek, 
Roche Diabnostics, GmbH, Germany). 
 
2.9.2. Effect of methanolic extracts in 
Normoglycemic rats 
The rats were divided into six groups of 6 
animals (n=6) each. Group I served as control 
and received saline water. Group II served as 
standard control, received Metformin in the 
vehicle (100mg/kg, p.o.). Group III, IV, V, VI 
received 150 and 300 mg/kg MNLS and MNLP 
orally respectively. Blood glucose levels were 
determined at 0, 1, and 2 hr following 
treatment from tail vein. 
  
2.9.3. Study on Alloxan-induced diabetic rats  
The experimental rodents were randomly 
divided into six groups consisting of 6 rats in 
each group. The groups were denoted as 
group-I, group-II, group-III, group- IV, group-V 
and group-VI. Each group of rats received a 
specific treatment. Test samples at a dose of 
150 mg/kg and 300 mg/kg body weight of rats 
were used to evaluate the hypoglycemic 
activity. Standard Metmorfoin was used at a 
dose of 100mg/kg body weight. Before 
administering the drugs, each rat was weighed 
properly and the doses were adjusted 
accordingly. In the evaluation of the 
hypoglycemic effect, the blood glucose level of 
the experimental animals were measured at 0 
hour by tail tipping method (Durschlag et al., 
1996) using a glucometer (Bioland G-423S). 
Then the control, standard, MNLS and MNLP 
extracts and their different fractions were 
administered orally to the experimental 
animals with the help of feeding needle. Blood 
samples were collected from tail vein prior to 
dosing (day 0) and then at regular intervals of 
day 1, 3 and7 respectively. 
 
3. Statistical Analysis 
 
All the values in the test are expressed as 
mean ± standard error of the mean (SEM). 
The data      were statistically analyzed by 
ANOVA (Analysis of variance) and post-hoc 
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Dunnett’s tests with the Statistical Package for 
Social Sciences (SPSS) program (SPSS 16.0, 
USA). Dissimilarity between the means of the 
various groups were measured significant at P 
< 0.05. 
 
4. Result 
 
4.1. Phytochemical analysis  
The extracts gave positive tests for tannins, 
alkaloids, and flavonoids (Table 1). 
 
4.2. Acute toxicity  
In the acute toxicity test, the plant extracts 
were found to be safe up to doses of 1.6 g/kg.  
Behavior of the animals was strictly observed 
for the first 3 in the next 48 h. The extracts did 
not affect any behavioral change or mortality 
on rats during 48 h inspection. 
 
 
Table 2: Oral glucose tolerance test in rat for N.longan fruit 
 
4.3. Oral glucose tolerance test 
In oral glucose tolerance test, we have 
observed that both extracts was active and 
comparable to that of the glucose treated 
control group in both doses (Table-2). A good 
anti-hyperglycemic effect of  
 
MNLP was observed at 300mg/kg dose in the 
first hour after glucose loading in rats under 
OGTT. This effect was still present 180 min 
after the oral administration of glucose. MNLS 
was also shown to be hypoglycemic at higher 
dose. 
Table 1: Phytochemical constituents of different extracts of D.longan fruit seeds 
Extract
s 
Flavonoi
d 
Tannin Alkaloid Saponi
n 
Carbohydrate 
MNLS + + + - - 
MNLP + + + - - 
Here, (+): Present; (-): Absent 
 
4.4. Normoglycemic study 
In case of normoglycemic test we have 
observed that administration of single dose of 
both MNLS and MNLP in normal rats showed 
reduction in blood glucose levels at different 
time intervals compared to 0 h of the same 
group. As shown in Table-3, oral 
administration of MNLS (300 mg/kg) and 
MNLP(300 mg/kg) caused a significant 
(P<0.05) reduction in glucose levels 
respectively at 2 h  and 3h as compared to 
normal control group. 
 
Table 3: Effect of on Blood Glucose in Normoglycemic rat 
Group 
 
Design of 
Treatment 
 
Dose 
mg/kg 
Blood glucose levels (mmol/l) 
0hr 1hr 2hr 
I N.saline  7.216 ± 0.16415 7.116 ± 0.15794 7.133 ± 0.15635 
II Standard 150 9.65 ± 0.46601 *  6.7 ± 0.52915 3.77 ± 0.32318 *  
III MNLS-150 150 8.166 ± 0.25647 7.18 ± 0.26635 6.03 ± 0.31588 
IV MNLS -300 300 7.883 ± 0.27131 5.72 ± 0.38333 *  4.08 ± 0.39616 *  
V MNLP-150 150 7.866 ± 0.25906 6.7 ± 0.30441 5.65 ± 0.33441 *  
VI MNLP-300 300 7.883 ± 0.27131 5.87 ± 0.28008 4.47 ± 0.24037 *  
All values are expressed as mean ± STD (n=6); One-Way Analysis of Variance (ANOVA) followed by Dunnet’s 
test. *P<0.05 significant compared to control. 
 
Group Initial (mmol/L) 1 h (mmol/L 2 h (mmol/L) 3 h (mmol/L) 
G-I (Control) 8.32 ± 0.11949 6.67 ± 0.07149 4.92 ± 0.12494 3.83 ± 0.14063 
G-II (Standard) 9.47 ± 0.18559 *  7.65 ± 0.36492 4.22 ± 0.29486 3.02 ± 0.19221 
G-III (MNLS-150) 9.87 ± 0.35653 *  8.58 ± 0.33903 *  7.53 ± 0.39129 *  6.47 ± 0.33632 *  
G-IV (MNLS-300) 10.18 ± 0.19322 *  8.33 ± 0.16667 *  6.43 ± 0.26667 *  5.2 ± 0.26667 *  
G-V (MNLP-150) 10.73 ± 0.34416 *  9.33 ± 0.39215 *  8.05 ± 0.39306 *  6.98 ± 0.26384 *  
G-VI (MNLP-300) 10.33 ± 0.28944 *  7.47 ± 0.19944 5.63 ± 0.24037 3.58 ± 0.37454 
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Table 4: Blood glucose level of alloxan induced diabetic rat after treatment with MNLS &MNLP 
Group 
 
Design of 
Treatment 
Dose 
mg/kg 
Blood glucose levels (mmol/l) 
1st day 3rd  day 7th day 
I N.saline  7.0667 ± 0.07149 6.9500 ± 0.04282 7.0833 ± 0.03073 
II Control ( diabetic)  15.0000 ± 0.36515 *  17.5833 ± 0.20069 *  19.7500 ± 0.17078 *  
II Standard 150 12.466 ± 0.67511 *  5.533 ± 0.27039 3.58 ± 0.35816 
III MNLS-150 150 12.466 ± 0.67511 *  5.533 ± 0.27039 3.58 ± 0.35816 *  
IV MNLS -300 300 17.67 ± 0.42164 *  11.95 ± 0.69940 *  8.08 ± 0.49018 
V MNLP-150 150 15.83 ± 1.19490 *  10.33 ± 0.76012 *  6.88 ± 0.27131 
VI MNLP-300 300 16. ± 0.68313 *  11.50 ± 0.76376 *  7.17 ± 0.16667 
All values are expressed as mean ± STD (n=6); One-Way Analysis of Variance (ANOVA) followed by Dunnet’s 
test. *P<0.05 significant compared to control 
 
 4.5. Effect on blood glucose level of 
hyperglycemic rats  
Table 4 illustrates the effect of graded doses 
of methanolic extracts of seeds and peel of N. 
Longan on blood glucose level of 
hyperglycemic rats. There was significant 
decrease in the blood glucose levels at 1st, 3rd   
day (P<0.05) with 150 and 300mg/kg doses of 
MNLS and MNLP extracts were reported. 
 
5. Discussion 
 
From the dawn of human civilization herbal 
medicines have been used for the 
management of diabetes and persist to be 
presently established as a choice of therapy. 
Noticeably huge numbers of anti-diabetic 
herbs are identified through folklore, however 
pharmacological assessment by scientific 
methods is obligatory to establish the 
antidiabetic activity. The study of such 
medicines might propose a natural key to 
unlock a diabetologist’s pharmacy for the 
future (Venkateshwarlu et al., 2009). The 
economic disaster, elevated expenditure of 
industrialized medicines, disorganized 
community access to medical and 
pharmaceutical care, in addition to the side 
effects caused by synthetic drugs are some of 
the issues contributing to the vital role of 
medicinal plants in health care (Johann et al., 
2007). Although huge number of antidiabetic 
medicines is now available in pharmaceutical 
market, still remedies from medicinal plant are 
used with success to treat this disease. Plant 
drugs and herbal formulations are repeatedly 
considered to be less toxic and free from side 
effects than synthetic ones. According to 
WHO, hypoglycemic agents of plant source 
used in traditional medicine are essential. The 
attributed anti-hyperglycemic property of these 
plants is due to their capability to refurbish the 
role of pancreatic tissues by causing a boost in 
insulin output or diminish in the intestinal 
absorption of glucose. Therefore, healing with 
herbal drugs to protect β-cells and smoothing 
out oscillation in glucose levels. In common 
there is very tiny biological knowledge on the 
specific modes of action in the treatment of 
diabetes, but most of the plants have been 
found to contain substances like glycosides, 
alkaloids, terpenoids, flavonoids etc. that are 
frequently implicated as having antidiabetic 
effects. The research for alternate remedies 
(from the plant kingdom) for diabetes mellitus 
will continue all over the world as the disease 
posses many challenges not only to the 
physician but also to the researcher. The 
current research is a preliminary estimation of 
hypoglycemic and antihyperglycemic activity of 
methanolic extracts of peel (MNLP) and seeds 
(MNLP) of N. longan at 150 and 300 mg/kg in 
rodents. The phytochemical screening 
revealed that the plant extracts showed 
positive result to alkaloids, tannins and 
flavonoids. It has been well-established that 
most medicinal plants contain phenolic 
compounds and bioflavonoids that have 
outstanding antioxidant and antidiabetic 
properties. We also knew that diabetes is of 
two categories out of which one is genetically 
based and other as a result of dietary 
indiscretion (Dave and Katyare, 2002). Alloxan 
leads to a fall in insulin release there by a 
drastic diminution in plasma insulin 
concentration leading to stable hyperglycemic 
states (Yasodha et al., 2008). It induces 
diabetes by dose dependent destruction of β-
cells of islets of langrhans (Szkudelski, 2001; 
Murthy et al., 2004). So, in the present study 
alloxan was chosen to create diabetic 
condition in rat and significant hyperglycemia 
was achieved within 48 hours after alloxan 
(110g/kg b.w. i.p) injection. The results (Table 
2) proved that after a single administration of 
glucose 2gm/kg in rat, there was a significant 
reduction (p < 0.05) of fasting blood glucose 
level during the 3 h study period for both 
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extracts at 150mg/kg and 300 mg/kg doses. In 
alloxanised rats, administration of MNLS and 
MNLP at the above mentioned doses up to 7 
days was able to correct this abnormality 
about to normal range. Additionally, MNLS and 
MNLP illustrated similar significant lowering of 
blood glucose level in OGTT and 
normoglycemic rats. These observations 
suggest that the experimental extract might 
acquire insulin like effect on peripheral tissues 
either by promoting glucose consumption 
metabolism or inhibiting hepatic 
gluconeogenesis since alloxan treatment 
causes permanent destruction of ß cells (Pari 
and Venkateswaran, 2002). 
 
In acute toxicity animals of any group did not 
show. As no mortality or toxic effect was 
observed during 48 hours acute toxicity 
experiment, LD50 was not calculated. 
 
Any toxic effect numerous authors stated that 
phenolic acids, flavonoids, steroids/terpenoids, 
are known to be bioactive antidiabetic 
principles (Oliver-Bever, 1986; Rhemann and 
Zaman, 1989). Since the phytochemical 
analysis of the experimented crude extracts 
has shown the presence of potent 
phytochemicals like alkaloids, flavonoids and 
tannin. Therefore the crude extracts might be 
new sources of expansion of new plant based 
therapy for management of diabetes. But we 
still don’t know which chemical components 
are exactly accountable with the aforesaid 
effects so to find out the lead compounds 
responsible for aforesaid activities from the 
above plant are in progress. 
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